Arkolith/Insider Trading/AARD/Form 4

Lee Tien-Li

Chief Executive Officer, Director, 10% OwnerAardvark Therapeutics, Inc. (AARD) · full profile →Form 4 · filed Feb 19, 2025
Net Buying
Open-Market Buys
$265K
Open-Market Sells
$0
Net Open-Market Flow
$265K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2025Buy(P)17K$16.00$265K1.5M
Feb 14, 2025Conversion(C)41K——1.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2025Conversion(C)350K—$00

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-023253) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML